Know Cancer

or
forgot password

    • cancer clinical trials in camden, NJ

    • Combination Chemotherapy With or Without G-CSF in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer
    Cooper Hospital/University Medical Center
    Camden, New Jersey 08103
    Endometrial Cancer
    Quality of Life in Survivors of Gynecologic Cancer
    Cooper Hospital/University Medical Center
    Camden, New Jersey 08103
    Endometrial Cancer, Ovarian Cancer
    Diagnostic Study of Patients With Aggressive Non-Hodgkin's Lymphoma
    Cancer Institute of New Jersey at the Cooper University Hospital
    Camden, New Jersey 08103-1489
    Lymphoma
    Paclitaxel Plus Carboplatin With or Without SCH-58500 in Treating Patients With Newly Diagnosed Stage III Ovarian or Stage III Primary Peritoneal Cancer
    Cooper Hospital/University Medical Center
    Camden, New Jersey 08103
    Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Danazol in Treating Patients With Advanced or Recurrent Endometrial Cancer
    Cooper Hospital/University Medical Center
    Camden, New Jersey 08103
    Endometrial Cancer
    Topotecan Plus Etoposide in Treating Patients With Recurrent Ovarian, Peritoneal, or Fallopian Tube Cancer
    Cooper Hospital/University Medical Center
    Camden, New Jersey 08103
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Docetaxel in Treating Patients With Recurrent or Refractory Ovarian or Primary Peritoneal Cancer
    Cooper Hospital/University Medical Center
    Camden, New Jersey 08103
    Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III Ovarian Cancer
    Cooper Hospital/University Medical Center
    Camden, New Jersey 08103
    Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Combination Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cancer
    Cooper Hospital/University Medical Center
    Camden, New Jersey 08103
    Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Topotecan in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal Cancer
    Cooper Hospital/University Medical Center
    Camden, New Jersey 08103
    Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Irofulven in Treating Patients With Persistent or Recurrent, Refractory Endometrial Cancer
    Cooper Hospital/University Medical Center
    Camden, New Jersey 08103
    Endometrial Cancer
    Chemotherapy in Treating Patients With Sarcoma of the Uterus
    Cooper Hospital/University Medical Center
    Camden, New Jersey 08103
    Endometrial Cancer, Sarcoma
    Oxaliplatin in Treating Patients With Recurrent or Refractory Ovarian Epithelial Cancer or Primary Peritoneal Cancer That Has Not Responded to Platinum- Based Chemotherapy
    Cooper Hospital/University Medical Center
    Camden, New Jersey 08103
    Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Oxaliplatin in Treating Patients With Recurrent or Refractory Cervical Cancer
    Cooper Hospital/University Medical Center
    Camden, New Jersey 08103
    Cervical Cancer
    Combination Chemotherapy Plus Fluoxetine in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer
    Cooper University Hospital
    Camden, New Jersey 08103
    Anxiety Disorder, Depression, Fatigue, Lung Cancer
    Radiation Therapy With or Without RSR13 in Treating Patients With Brain Metastases
    Cooper Hospital/University Medical Center
    Camden, New Jersey 08103
    Metastatic Cancer
    Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
    Cooper University Hospital
    Camden, New Jersey 08103
    Lymphoma
    Gemcitabine in Treating Patients With Persistent or Recurrent Cancer of the Cervix
    Cooper Hospital/University Medical Center
    Camden, New Jersey 08103
    Cervical Cancer
    Gemcitabine and Cisplatin in Treating Patients With Refractory or Recurrent Cancer of the Cervix
    Cooper Hospital/University Medical Center
    Camden, New Jersey 08103
    Cervical Cancer
    Capecitabine in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal Cavity Cancer
    Cooper Hospital/University Medical Center
    Camden, New Jersey 08103
    Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Combination Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer or Primary Peritoneal Cancer
    Cooper University Hospital
    Camden, New Jersey 08103
    Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Combination Chemotherapy in Treating Patients With Bladder Cancer
    Cancer Institute of New Jersey at the Cooper University Hospital
    Camden, New Jersey 08103-1489
    Bladder Cancer
    Radiation Therapy and Cisplatin With or Without Epoetin Alfa in Treating Patients With Cervical Cancer and Anemia
    Cooper University Hospital
    Camden, New Jersey 08103
    Anemia, Cervical Cancer, Drug/Agent Toxicity by Tissue/Organ, Radiation Toxicity
    Tirapazamine Plus Cisplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial or Primary Peritoneal Cancer
    Cooper Hospital/University Medical Center
    Camden, New Jersey 08103
    Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Zoledronate, Calcium, and Vitamin D in Preventing Bone Loss in Women Receiving Adjuvant Chemotherapy for Breast Cancer
    Cancer Institute of New Jersey at the Cooper University Hospital - Voorhees
    Camden, New Jersey 08103
    Breast Cancer, Osteoporosis
    Gefitinib in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer or Primary Peritoneal Cancer
    Cooper Hospital/University Medical Center
    Camden, New Jersey 08103
    Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Surgery With or Without Chemotherapy and Radiation Therapy in TreatingPatients With Stage I Rectal Cancer
    Cooper University Hospital
    Camden, New Jersey 08103
    Colorectal Cancer
    Flavopiridol in Treating Patients With Recurrent or Persistent Endometrial Cancer
    Cooper Hospital/University Medical Center
    Camden, New Jersey 08103
    Endometrial Cancer
    Combination Chemotherapy and Radiation Therapy in Treating Patients With Pancreatic Cancer
    Cooper University Hospital
    Camden, New Jersey 08103
    Pancreatic Cancer
    Fibrin Sealant in Decreasing Lymphedema Following Surgery to Remove Lymph Nodes in Patients With Cancer of the Vulva
    Cancer Institute of New Jersey at the Cooper University Hospital - Voorhees
    Camden, New Jersey 08103
    Lymphedema, Perioperative/Postoperative Complications, Vulvar Cancer
    Liposomal Doxorubicin in Treating Patients With Persistent or Recurrent Cancer of the Cervix
    Cooper University Hospital
    Camden, New Jersey 08103
    Cervical Cancer
    Combination Chemotherapy and Filgrastim or Pegfilgrastim in Treating Patients With Recurrent or Persistent Cancer of the Uterus
    Cancer Institute of New Jersey at the Cooper University Hospital - Voorhees
    Camden, New Jersey 08103
    Sarcoma
    Combination Chemotherapy and Computer-Planned Radiation Therapy in Treating Patients With Unresectable Stage III Non-Small Cell Lung Cancer
    Cancer Institute of New Jersey at the Cooper University Hospital
    Camden, New Jersey 08103-1489
    Lung Cancer
    Combination Chemotherapy Plus Sargramostim in Treating Patients With Cancer of the Uterus
    Cooper University Hospital
    Camden, New Jersey 08103
    Sarcoma
    Vaccine Therapy in Treating Patients With Colorectal Cancer Metastatic to the Liver
    Cooper University Hospital
    Camden, New Jersey 08103
    Colorectal Cancer, Neoplasm Metastasis
    Capecitabine in Treating Patients With Persistent or Recurrent Cervical Cancer
    Cancer Institute of New Jersey at the Cooper University Hospital
    Camden, New Jersey 08103-1489
    Cervical Cancer
    Celecoxib in Treating Women With Metastatic or Recurrent Breast Cancer
    Cancer Institute of New Jersey at the Cooper University Hospital
    Camden, New Jersey 08103-1489
    Breast Cancer
    Chemotherapy and Radiation Therapy With or Without Surgery in Treating Patients With Head and Neck Cancer
    Cancer Institute of New Jersey at the Cooper University Hospital
    Camden, New Jersey 08103-1489
    Head and Neck Cancer
    Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving Chemotherapy
    Cooper University Hospital
    Camden, New Jersey 08103
    Colorectal Cancer, Diarrhea, Neutropenia
    Radiation Therapy in Preventing CNS Metastases in Patients With Non-Small Cell Lung Cancer
    Cancer Institute of New Jersey at Cooper University Hospital - Camden
    Camden, New Jersey 08103
    Lung Cancer
    Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Cancer
    Cancer Institute of New Jersey at the Cooper University Hospital - Voorhees
    Camden, New Jersey 08103
    Leukemia, Lymphoma, Multiple Myeloma, Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myeloproliferative Neoplasms
    Pemetrexed Disodium and Gemcitabine in Treating Patients With Advanced Cancer of the Urothelium
    Cancer Institute of New Jersey at the Cooper University Hospital - Voorhees
    Camden, New Jersey 08103
    Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Urethral Cancer
    PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
    Cancer Institute of New Jersey at the Cooper University Hospital
    Camden, New Jersey 08103-1489
    Malignant Mesothelioma
    Karenitecin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer
    Cooper University Hospital
    Camden, New Jersey 08103
    Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Metastatic Colorectal Cancer.
    Cooper Cancer Institute
    Camden, New Jersey 08103
    Colorectal Neoplasms, Colonic Neoplasms, Rectal Neoplasms
    Polyglutamate Paclitaxel and Carboplatin in Treating Patients With Ovarian Epithelial, Peritoneal, or Fallopian Tube Cancer
    Cancer Institute of New Jersey at the Cooper University Hospital - Voorhees
    Camden, New Jersey 08103
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Cisplatin and Ifosfamide Combined With Either Paclitaxel or Vinblastine in Treating Men With Progressive or Recurrent Metastatic Germ Cell Tumors
    Cancer Institute of New Jersey at the Cooper University Hospital
    Camden, New Jersey 08103-1489
    Extragonadal Germ Cell Tumor, Testicular Germ Cell Tumor
    Octreotide in Preventing or Reducing Diarrhea in Patients Receiving Chemoradiotherapy for Anal or Rectal Cancer
    Cancer Institute of New Jersey at Cooper University Hospital - Camden
    Camden, New Jersey 08103
    Anal Cancer, Colorectal Cancer, Drug/Agent Toxicity by Tissue/Organ, Radiation Enteritis
    Docetaxel and Cisplatin With or Without Dimesna in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
    Cancer Institute of New Jersey at the Cooper University Hospital - Voorhees
    Camden, New Jersey 08103
    Anemia, Drug/Agent Toxicity by Tissue/Organ, Lung Cancer, Neutropenia
    Trastuzumab, Ixabepilone, and Carboplatin in Treating Patients With HER2/Neu-Positive Metastatic Breast Cancer
    Cancer Institute of New Jersey at the Cooper University Hospital - Voorhees
    Camden, New Jersey 08103
    Breast Cancer
    Paclitaxel, Bevacizumab And Adjuvant Intraperitoneal Carboplatin in Treating Patients Who Had Initial Debulking Surgery for Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
    Cooper Hospital University Medical Center
    Camden, New Jersey 08103
    Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Stage II Ovarian Epithelial Cancer, Stage III Ovarian Epithelial Cancer, Stage IV Ovarian Epithelial Cancer
    Study of TLK286 (Telcyta) vs. Gefitinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer
    Cooper Cancer Institute
    Camden, New Jersey 08103
    Non Small Cell Lung Carcinoma
    Study of Therapy With TransMID™ Compared to Best Standard of Care in Patients With Glioblastoma Multiforme
    Cooper University Hospital
    Camden, New Jersey 08103
    Glioblastoma Multiforme
    Docetaxel in Treating Patients With Recurrent or Persistent Endometrial Carcinoma (Cancer)
    Cancer Institute of New Jersey at the Cooper University Hospital
    Camden, New Jersey 08103-1489
    Endometrial Cancer
    Carboplatin and Paclitaxel With or Without Bevacizumab Compared to Docetaxel, Carboplatin, and Paclitaxel in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Carcinoma (Cancer)
    Cooper Hospital University Medical Center
    Camden, New Jersey 08103
    Brenner Tumor, Fallopian Tube Cancer, Ovarian Carcinosarcoma, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Stage II Ovarian Epithelial Cancer, Stage III Ovarian Epithelial Cancer, Stage IV Ovarian Epithelial Cancer